Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Effectiveness of a positive psychology and mindfulness-based app on mental health for parents of children with a neurodevelopmental disorder: study protocol of a pragmatic international randomized controlled trial.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
- بيانات النشر:
Original Publication: [London] : BioMed Central, 2006-
- الموضوع:
- نبذة مختصرة :
Introduction: Parents of children with a neurodevelopmental disorder (NDD) experience more stress than parents of typically developing children. In a cocreation process with experts and parents, a low-threshold application that uses exercises based on the principles of positive psychology and mindfulness was developed. This application, called "Adappt," aims at enhancing the ability to adapt of the parents and caregivers of children with NDDs and at supporting their mental health. This protocol describes the evaluation study of the effectiveness of Adappt, its core working mechanisms and user experiences.
Method: A pragmatic international multicenter randomized controlled trial will compare the effectiveness of Adappt with a (delayed) waitlist control condition. At least 212 parents or primary caregivers of children younger than 18 years diagnosed with or suspected of a NDD will be randomly assigned to the intervention or waitlist control condition. Participants are excluded if they have severe anxiety or depression levels or are in treatment for mental health issues. Measures will be collected online at baseline, post-intervention (1 month after baseline), and 4 and 7 months after baseline. The primary outcome is the improvement in generic sense of ability to adapt as measured with the Generic Sense of Ability to Adapt Scale (GSAAS; (Front Psychol 14:985408, 2023)) at 4-month follow-up. Secondary outcomes are mental well-being, (parental) distress, and client satisfaction with "Adappt."
Discussion: Results of this study will contribute to knowledge on the effectiveness of a low-threshold application for parents of children with a NDD in multiple countries. If the application is found to be effective in improving mental health, recommendations will be made for implementation in health care.
Trial Registration: This study is registered on clinicaltrials.gov (NCT06248762) on February 8, 2024, and the Open Science Framework ( https://osf.io/5znqv ).
(© 2024. The Author(s).)
- References:
Am J Orthopsychiatry. 2006 Oct;76(4):564-75. (PMID: 17209724)
J Pers Soc Psychol. 2003 Apr;84(4):822-48. (PMID: 12703651)
Front Psychol. 2018 Feb 19;9:181. (PMID: 29515496)
J Autism Dev Disord. 2019 Oct;49(10):3983-3998. (PMID: 31197635)
Res Dev Disabil. 2016 Jun-Jul;53-54:158-77. (PMID: 26921524)
J Psychosom Res. 2010 Jun;68(6):539-44. (PMID: 20488270)
J Med Internet Res. 2012 Nov 14;14(6):e152. (PMID: 23151820)
Br J Clin Psychol. 2004 Mar;43(Pt 1):31-50. (PMID: 15005905)
Eval Program Plann. 1982;5(3):233-7. (PMID: 10259963)
Clin Psychol Psychother. 2008 May-Jun;15(3):181-92. (PMID: 19115439)
BMJ Open. 2019 Mar 20;9(3):e022695. (PMID: 30898795)
Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
Curr Opin Psychiatry. 2022 Sep 1;35(5):345-351. (PMID: 35165244)
Behav Ther. 2011 Dec;42(4):676-88. (PMID: 22035996)
Healthcare (Basel). 2021 Dec 28;10(1):. (PMID: 35052216)
Psychiatry Res. 2016 Aug 30;242:121-129. (PMID: 27280521)
J Psychosom Res. 2011 Aug;71(2):74-8. (PMID: 21767686)
Child Adolesc Psychiatry Ment Health. 2022 Mar 31;16(1):27. (PMID: 35361232)
J Autism Dev Disord. 2013 Mar;43(3):629-42. (PMID: 22790429)
Hong Kong J Occup Ther. 2022 Jun;35(1):3-24. (PMID: 35847187)
Front Psychol. 2023 Mar 29;14:985408. (PMID: 37063565)
Clin Psychol Rev. 2020 Feb;75:101811. (PMID: 31884148)
Front Psychol. 2017 Dec 13;8:2075. (PMID: 29321750)
Issues Ment Health Nurs. 2016;37(3):153-63. (PMID: 27028741)
J Pediatr Nurs. 2016 Nov - Dec;31(6):567-579. (PMID: 27637421)
Asian Nurs Res (Korean Soc Nurs Sci). 2012 Dec;6(4):121-7. (PMID: 25031113)
J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417)
Contemp Clin Trials Commun. 2018 Mar 28;10:80-85. (PMID: 29696162)
J Psychosom Res. 2002 Feb;52(2):69-77. (PMID: 11832252)
J Clin Psychol. 2011 Jan;67(1):99-110. (PMID: 20973032)
PLoS One. 2021 May 24;16(5):e0252089. (PMID: 34029355)
Phys Occup Ther Pediatr. 2010 Nov;30(4):340-50. (PMID: 20735198)
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820)
J Happiness Stud. 2022;23(8):4001-4025. (PMID: 36245700)
J Atten Disord. 2015 Oct;19(10):831-43. (PMID: 24915737)
Clin Psychol Rev. 2017 Feb;51:1-14. (PMID: 27816800)
J Med Internet Res. 2005 Mar 31;7(1):e11. (PMID: 15829473)
Pediatrics. 2011 May;127(5):e1303-11. (PMID: 21464190)
Biol Psychiatry. 2021 Aug 15;90(4):253-262. (PMID: 34116791)
Pediatrics. 2014 Aug;134(2):e454-63. (PMID: 25049350)
Ann Intern Med. 2013 Feb 5;158(3):200-7. (PMID: 23295957)
Psychol Assess. 2018 Jun;30(6):729-743. (PMID: 28795825)
Curr Opin Psychiatry. 2015 Mar;28(2):121-6. (PMID: 25594421)
J Pharmacol Pharmacother. 2010 Jul;1(2):100-7. (PMID: 21350618)
Front Psychol. 2021 Jun 04;12:695147. (PMID: 34149578)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
J Affect Disord. 2021 Jan 15;279:131-142. (PMID: 33049431)
J Clin Psychol. 2009 May;65(5):467-87. (PMID: 19301241)
- Grant Information:
101057385 HORIZON EUROPE Framework Programme
- Contributed Indexing:
Keywords: ADHD; Ability to adapt; Adappt; Application; Autism; Digital intervention; Effectiveness; Neurodevelopmental disorder; Parents; RCT; Randomized controlled trial; Self-help; Well-being
- Molecular Sequence:
ClinicalTrials.gov NCT06248762
- الموضوع:
Date Created: 20240626 Date Completed: 20240627 Latest Revision: 20240828
- الموضوع:
20240828
- الرقم المعرف:
PMC11210113
- الرقم المعرف:
10.1186/s13063-024-08256-w
- الرقم المعرف:
38926739
No Comments.